Tilray | TRLY - 流动负债

股票价格

9.23

每天变化

-0.23 -2.43%

每月一次

-3.75%

每年

1,237.68%

Q2 预测

9.04

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 7.16B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	流动负债	更改		日
Acasti Pharma	USD 1.24M		1.08M	2025-09
Akebia Therapeutics	USD 162.94M		29.56M	2025-12
Alaunos Therapeutics	USD 921K		153K	2025-09
Aurora Cannabis	CAD 145.94M		21.82M	2025-12
Avita Medical	AUD 62.68M		77K	2025-12
Canopy Growth	CAD 98.29M		17.19M	2025-12
Cronos Group	USD 48.19M		7.12M	2025-12
Dianthus Therapeutics	USD 30.73M		6.88M	2025-12
Divis Laboratories Ltd	INR 17.28B		2.76B	2025-09
Ionis Pharmaceuticals	USD 783M		120.46M	2025-12
IQVIA Holdings	USD 8.34B		170M	2025-12
Knight Therapeutics	CAD 165.26M		12.58M	2025-12
Moderna	USD 1.99B		306M	2025-12
Organigram Holdings	CAD 94.05M		32.11M	2025-12
Organon & Co	USD 2.68B		117M	2025-09
Revvity	USD 1.33B		108.5M	2025-12
Tectonic Therapeutic	USD 9.67M		293K	2025-12
Tilray	USD 259.32M		8.32M	2025-09
Viatris	USD 7.09B		269.8M	2025-12
Xeris Pharmaceuticals	USD 109.57M		6.63M	2025-12
Zealand Pharma A/S	664.96M		513.61M	2025-12